Ro 24-7429
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ro 24-7429, covering 2008-08-04 to 2008-08-04. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection [Phase 1]